Long COVID and pain

Mark Loeb, MD, MSc, is a professor in the Department of Pathology and Molecular Medicine and Department of Clinical Epidemiology and Biostatistics and director of the Division of Infectious Diseases at McMaster University.

What type of pain is most prevalent in long coronavirus disease (COVID) and how to manage it?

Most of the studies that have looked at pain in long COVID haven’t really characterized it very well. Just general aches or chest pain. But I’m not aware of many studies that have used specific scales to quantify the level of pain.

See also

Important recent reports in infectious diseases Have there been any breakthrough reports or any new important guidelines in the field of infectious diseases?
Three years of COVID: A look into the past and the present Dr Dominik Mertz and Dr Zain Chagla from McMaster University provide an update on the epidemiology, treatment, and prevention of COVID-19.
Antibacterial prophylaxis in patients with neutropenia When should patients with neutropenia receive antibiotics for infection prevention? Which agents and regimens should be used? Should antibiotics be used in patients with extreme non-chemotherapy-induced neutropenia who are not more prone to infections than the general population?
Glucocorticoid use in patients with COVID-19 in South Asia As far as you are in a position to judge, in what ways was the response to COVID-19 different in South Asian countries compared with the rest of the world?
Lessons from the COVID-19 pandemic What should the COVID-19 pandemic teach us in terms of the risk of future international-scale epidemics? What lessons on public health should we learn from the course of this pandemic?

Long COVID and pain

Social Media